BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
36.85
+0.05 (0.12%)
At close: Feb 21, 2025, 4:00 PM
36.81
-0.04 (-0.11%)
After-hours: Feb 21, 2025, 4:00 PM EST
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $6.96 billion as of February 21, 2025. Its market cap has increased by 19.04% in one year.
Market Cap
6.96B
Enterprise Value
8.01B
1-Year Change
19.04%
Ranking
Category
Stock Price
$36.85
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $6.96B, an increase of 109.78%. That is a compound annual growth rate of 13.99%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |